Does the use of acetylsalicylic acid have an influence on our vision?

References

• LiewGMitchellPWongTYRochtchinaEWangJJThe association of aspirin use with age-related macular degenerationJAMA Intern Med2013173425826423337937
   PubMed Web of Science ®Google Scholar
• JaniecWFarmakodynamika Podręcznik dla studentów farmacji [Pharmacodynamics Handbook for Pharmacy Students]924WarszawaWydawnictwo Lekarskie PZWL2008926
   Google Scholar
• PascheBWangMPennisonMJimenezHPrevention and treatment of cancer with aspirin: where do we stand?Semin Oncol201441339740125023355
   PubMed Web of Science ®Google Scholar
• NowakJZAspirin and age-related macular degeneration: positives versus negativesExpert Opin Drug Saf201413668724783984
   PubMed Web of Science ®Google Scholar
• KorbutROlszaneckiRWołkowPJawieńJFarmakologia [Pharmacology]WarszawaWydawnictwo Lekarskie PZWL2012178179
   Google Scholar
• MurrayRKGrannerDKRodwellVWBiochemia Harpera [Harper’s Biochemistry]2526th edWarszawaWydawnictwo Lekarskie PZWL2012254
   Google Scholar
• BańkowskiEBiochemiaPodręcznik dla studentów uczelni medycznych [Biochemistry. Handbook for Students of Medical Universities]2nd edWrocławElsevier Urban & Partner2008447448451452
   Google Scholar
• MamcarzAFarmakoterapia kardiologiczna [Cardiological Pharmacotherapy]1WarszawaMedical Education2011356
   Google Scholar
• KlaverCWolfsRAssinkJvan DuijnCMHofmanAde JongPTGenetic risk of age-related maculopathy. Population-based familial aggregation studyArch Ophthalmol199811612164616519869796
   PubMedGoogle Scholar
• EdwardsAORitterRAbelKJManningAPanhuysenCFarrerLAComplement factor H polymorphism and age-related macular degenerationScience2005308572042142415761121
   PubMed Web of Science ®Google Scholar
• HainesJLHauserMASchmidtSComplement factor H variant increases the risk of age-related macular degenerationScience2005308572041942115761120
   PubMed Web of Science ®Google Scholar
• FrancisPJZhangHDeWanAHohJKleinMLJoint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian populationMol Vis2008141395140018682806
   PubMed Web of Science ®Google Scholar
• KleinRJZeissCChewEYComplement factor H polymorphism in age-related macular degenerationScience2005308572038538915761122
   PubMed Web of Science ®Google Scholar
• KlaverCCKliffenMvan DuijnCMGenetic association of apolipoprotein E with age-related macular degenerationAm J Hum Genet19986312002069634502
   PubMed Web of Science ®Google Scholar
• WylęgałaETeperSPiłatJZwyrodnienie plamki związane z wiekiem [Age-Related Macular Degeneration]WrocławWydawnictwo Medyczne Górnicki201123
   Google Scholar
• Wiktorowska-OwczarekANowakJZPatogeneza i profilaktyka AMD: rola stresu oksydacyjnego i antyoksydantów [Pathogenesis and prevention of AMD: the role of oxidative stress and antioxidants]Postępy Hig Med Dosw (online)201064333343 Polish20679689
   PubMedGoogle Scholar
• ChristenWGChewEYDoes long-term aspirin use increase the risk of neovascular age-related macular degeneration?Expert Opin Drug Saf201413442142924547895
   PubMed Web of Science ®Google Scholar
• KanskiJJBowlingBOkulistyka Kliniczna [Clinical Ophthalmology]WrocławElsevier Urban & Partner2013600604
   Google Scholar
• de JongPTChakravarthyURahuMAssociations between aspirin use and aging macula disorder. The European Eye StudyOphtalmology20121191112118
   PubMed Web of Science ®Google Scholar
• KleinBEHowardKPGangnonRDreyerJOLeeKEKleinRLong-term use of aspirin and age-related macular degenerationJAMA2012308232469247823288416
   PubMed Web of Science ®Google Scholar
• ChristenWGGlynnRJChewEYBuringJELow-dose aspirin and medical record–confirmed age-related macular degeneration in a randomized trial of womenOphthalmology2009116122386239219815293
   PubMed Web of Science ®Google Scholar
• WilsonHLSchwartzDMBhattHRMcCullochChEDuncanJLStatin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degenerationAm J Ophthalmol2004137461562415059698
   PubMed Web of Science ®Google Scholar
• Jończyk-SkórkaKŚliwczyńska-RodziewiczDJarmakAKowalskiJDoes acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?Pol Merkur Lekarski20153822514414925815614
   PubMedGoogle Scholar
• LiLLiWChenCZYiZHZhouYYIs aspirin use associated with age-related macular degeneration? A meta-analysisJ Clin Pharm Ther201540214415425475899
   PubMed Web of Science ®Google Scholar
• AronowMEKleinMLClemonsTEEffect of Aspirin Use on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2) ParticipantsInvest Ophthalmol Vis Sci20145513 ARVO abstract 2993
   Web of Science ®Google Scholar
• KahawitaSKCassonRJReprint of: aspirin use and early age-related macular degeneration: a meta-analysisCan J Ophthalmol201550suppl 12933
   Web of Science ®Google Scholar
• NowakJZNeowaskularyzacja oczna i terapia antyangiogenna [Ocular neovascularization and antiangiogenic therapy]Magazyn Lekarza Okulisty2013714546 Polish
   Google Scholar
• Głowińska-OlszewskaBŁuczyńskiWBossowskiAKomórki progenitorowe śródbłonka jako nowy marker funkcji endotelium w ocenie ryzyka chorób układu sercowo-naczyniowego [Endothelial progenitor cells as a new marker of endothelial function with respect to risk of cardiovascular disorders]Postepy Hig Med Dosw (online)201165815 Polish21357990
   PubMedGoogle Scholar
• LouJPovsicTJAllenJDThe effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel propertiesThromb Res2010126317517920434759
   PubMed Web of Science ®Google Scholar
• KuDNBlood flow in arteriesAnnu Rev Fluid Mech199729399434
   Web of Science ®Google Scholar
• JaroszykFBiofizyka. Podręcznik dla studentów [Biophysics. Handbook for Students]2nd edWarszawaWydawnictwo Lekarskie PZWL2008103104 updated and extended
   Google Scholar
• WatermanMFuhrmanBKeidarSHayekTAspirin promotes low density lipoprotein susceptibility to oxidative modification in healthy volunteersIsr Med Assoc J2009111273073420166339
   PubMed Web of Science ®Google Scholar
• NambiVThe use of myeloperoxidase as a risk marker for atherosclerosisCurr Atheroscler Rep20057212713115727728
   PubMedGoogle Scholar
• HermannMKapiotisSHofbauerRSeelosCHeldIGmeinerBSalicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acidFree Radic Biol Med1999269–101253126010381197
   PubMed Web of Science ®Google Scholar
• KośmickiMPraktyczna farmakoterapia choroby wieńcowej [Practical Pharmacotherapy of Coronary Heart Disease]1st edWarszawaWyd. Medyk20071920
   Google Scholar
• WuYZhuWLiYHYuJAspirin and age related macular degeneration; the possible relationshipMed Hypothesis Discov Innov Ophtalmol2013235968
   Google Scholar
• AlbertsBBrayDHopkinKJohnsonALewisJRaffMPodstawy biologii komórki część 2 [Fundamentals of Cell Biology Part 2]. wyd. II zmienioneWarszawaWydawnictwo Naukowe PWN2005715716
   Google Scholar
• KiernanDHariprasadSMRusuIMehtaSMielerWJagerREpidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degenerationRetina201030101573157821060269
   PubMed Web of Science ®Google Scholar
• YingGSMaguireMGDanielEAssociation between anti-platelet or anticoagulant drugs and retinal or subretinal hemorrhage in the comparison of age-related macular degeneration treatments trialsOphthalmology2016123235236026545320
   PubMed Web of Science ®Google Scholar
• ChristenWGGlynnRJAjaniUAAge-related maculopathy in a randomized trial of low-dose aspirin among US physiciansArch Ophthalmol200111981143114911483080
   PubMed Web of Science ®Google Scholar
• FriedmanEKrupskySLaneAMOcular blood flow velocity in age-related macular degenerationOphthalmology199510246406467724181
   PubMed Web of Science ®Google Scholar
• GrunwaldJEHariprasadSMDuPontJFoveolar choroidal blood flow in age-related macular degenerationInvest Ophthalmol Vis Sci19983923853909477998
   PubMed Web of Science ®Google Scholar
• GoldbergJFlowerdewGSmithEBrodyJATsoMOFactors associated with age-related macular degeneration: an analysis of data from the First National Health and Nutrition Examination SurveyAm J Epidemiol198812847007103421236
   PubMed Web of Science ®Google Scholar
• VingerlingJRDielemansIBotsMLHofmanAGrobbeeDEde JongPTAge-related macular degeneration is associated with atherosclerosis: the Rotterdam StudyAm J Epidemiol199514244044097625405
   PubMed Web of Science ®Google Scholar
• SperdutoRDHillerRSystemic hypertension and age-related maculopathy in the Framingham StudyArch Ophthalmol198610422162193947296
   PubMedGoogle Scholar
• XXXXRisk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupArch Ophthalmol199211012170117081281403
   PubMedGoogle Scholar
• de JongPTAge-related macular degenerationN Engl J Med2006355141474148517021323
   PubMed Web of Science ®Google Scholar
• SparrowJRUedaKZhouJComplement dysregulation in AMD: RPE-Bruch’s membrane-choroidMol Aspects Med201233443644522504022
   PubMed Web of Science ®Google Scholar
• AndersonDHMullinsRFHagemanGSJohnsonLVA role for local inflammation in the formation of drusen in the aging eyeAm J Ophthalmol2002134341143112208254
   PubMed Web of Science ®Google Scholar
• SerhanCNLipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in antiinflammation and pro-resolutionProstaglandins Other Lipid Mediat200268–69433455
   PubMed Web of Science ®Google Scholar
• GrosserNSchroderHAspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathwayArterioscler Thromb Vasc Biol2003231345135112829521
   PubMed Web of Science ®Google Scholar
• SteerKAWallaceTMBoltonCHHartogMAspirin protects low density lipoprotein from oxidative modificationHeart19977743333379155612
   PubMed Web of Science ®Google Scholar
• RaschkaCKochHJEtude pharmacocinetique apres administration orale et intraveineuse d’acetylsalicylate de DL-lysine et administration orale d’acide acetylsalicylique chez des volontaires sains. [Pharmacokinetics after oral and intravenous administration of d,l-monolysine acetylsalicylate and an oral dose of acetylsalicylic acid in healthy volunteers]Therapie2001566669674 French11878089
   PubMed Web of Science ®Google Scholar
• CzyżMWatałaCAspiryna – cudowne panaceum? Molekularne mechanizmy działania kwasy acetylosalicylowego w organizmie. [Aspirin – the prodigious panacea? Molecular mechanisms of the action of acetylsalicylic acid in the organism]Postepy Hig Med Dosw (online)200559105115 Polish15928593
   PubMedGoogle Scholar
• Paul-ClarkMJVan CaoTMoradi-BidhendiNCooperDGilroyDW15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammationJ Exp Med20042001697815238606
   PubMed Web of Science ®Google Scholar